{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T07:26:34Z","timestamp":1769498794598,"version":"3.49.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,5,6]],"date-time":"2011-05-06T00:00:00Z","timestamp":1304640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s12028-011-9552-5","type":"journal-article","created":{"date-parts":[[2011,5,5]],"date-time":"2011-05-05T16:01:20Z","timestamp":1304611280000},"page":"421-427","source":"Crossref","is-referenced-by-count":36,"title":["Cerebrovascular Events After Bevacizumab Treatment: An Early and Severe Complication"],"prefix":"10.1007","volume":"15","author":[{"given":"Raymond C. S.","family":"Seet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro A.","family":"Rabinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul E.","family":"Lindell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon H.","family":"Uhm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eelco F.","family":"Wijdicks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,6]]},"reference":[{"key":"9552_CR1","unstructured":"Genentech IA. South San Francisco, CA, Genentech, Inc. 2009."},{"key":"9552_CR2","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1200\/JCO.2007.10.7334","volume":"25","author":"K Margolin","year":"2007","unstructured":"Margolin K, Gordon M. Shortening the infusion time of anticancer drugs: who will benefit? J Clin Oncol. 2007;25:2642\u20133.","journal-title":"J Clin Oncol"},{"key":"9552_CR3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/JTO.0b013e318195a642","volume":"4","author":"T Tanvetyanon","year":"2009","unstructured":"Tanvetyanon T, Murtagh R, Bepler G. Rupture of a cerebral arteriovenous malformation in a patient treated with bevacizumab. J Thorac Oncol. 2009;4:268\u20139.","journal-title":"J Thorac Oncol"},{"key":"9552_CR4","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1200\/JCO.2009.22.0616","volume":"27","author":"MA Socinski","year":"2009","unstructured":"Socinski MA, Langer CJ, Huang JE, et al. Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases. J Clin Oncol. 2009;27:5255\u201361.","journal-title":"J Clin Oncol"},{"key":"9552_CR5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1:27\u201331.","journal-title":"Nat Med"},{"key":"9552_CR6","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1002\/cncr.25256","volume":"116","author":"MC Chamberlain","year":"2010","unstructured":"Chamberlain MC. Emerging clinical principles on the use of bevacizumab for the treatment of malignant gliomas. Cancer. 2010;116:3988\u201399.","journal-title":"Cancer"},{"key":"9552_CR7","first-page":"134","volume":"7","author":"B Kaur","year":"2005","unstructured":"Kaur B, Khwaja FW, Severson EA, Matheny SL, Brat DJ, Van Meir EG. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neurooncology. 2005;7:134\u201353.","journal-title":"Neurooncology"},{"key":"9552_CR8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11060-009-0098-8","volume":"99","author":"JBO Rieger","year":"2010","unstructured":"Rieger JBO, Muller K, Franz K, Steinbach J, Hattingen E. Bevacizumab-induced diffusion-restricted lesions in malignant glioma patients. J Neurooncol. 2010;99:49\u201356.","journal-title":"J Neurooncol"},{"key":"9552_CR9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1552-6569.2006.00071.x","volume":"17","author":"EH Wong","year":"2007","unstructured":"Wong EH, Leung TW, Wong KS. Stroke caused by small vessel occlusion in a patient taking etoricoxib and thalidomide. J Neuroimaging. 2007;17:87\u20138.","journal-title":"J Neuroimaging"},{"key":"9552_CR10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s004170050106","volume":"236","author":"FE Kruse","year":"1998","unstructured":"Kruse FE, Joussen AM, Rohrschneider K, Becker MD, Volcker HE. Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor. Graefes Arch Clin Exp Ophthalmol. 1998;236:461\u20136.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"9552_CR11","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm1428","volume":"12","author":"BY Tam","year":"2006","unstructured":"Tam BY, Wei K, Rudge JS, Hoffman J, Holash J, Park SK, Yuan J, Hefner C, Chartier C, Lee JS, Jiang S, Nayak NR, Kuypers FA, Ma L, Sundram U, Wu G, Garcia JA, Schrier SL, Maher JJ, Johnson RS, Yancopoulos GD, Mulligan RC, Kuo CJ. VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis. Nat Med. 2006;12:793\u2013800.","journal-title":"Nat Med"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-011-9552-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12028-011-9552-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-011-9552-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:14:27Z","timestamp":1559427267000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12028-011-9552-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,6]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["9552"],"URL":"https:\/\/doi.org\/10.1007\/s12028-011-9552-5","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,6]]}}}